Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis

Infection and Immunity

Volumn 64, Issue 11, 1996, Pages 4714-4718

  Fratti, Rutilio A ^a   Ghannoum, Mahmoud A ^a,b,c   Edwards Jr , John E ^a,b   Filler, Scott G ^a,b  

^a St John's Cardiovascular Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RECOMBINANT GAMMA INTERFERON;

ARTICLE; CANDIDA ALBICANS; CELL ADHESION; CELL PROTECTION; CYTOTOXICITY; ENDOTHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0029919377     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.11.4714-4718.1996     Document Type: Article

References (43)

1. Andreoli, S. P., and J. A. McAteer. 1 990. Reactive oxygen molecule mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int. 38:785-794.
2. Balla, G., G. Vercelloti, J. W. Eaton, and H. S. Jacob. 1990. Heme uptake by endothelium synergizes polymorphonuclear granulocyte-mediated damage. Trans. Assoc. Am. Phys. 103:174-179.
3. Blasi, E., S. Farinelli, L. Varesio, and F. Bistoni. 1990. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect. Immun. 58:1073-1077.
4. Brummer, E., C. J. Morrison, and D. A. Stevens. 1985. Recombinant and natural gamma-interieron activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect. Immun. 49:724-730.
5. Buettner, G. R. 1993. The spin trapping of superoxide and hydroxyl free radicals with DMPO (5,5-dimethylpyrrolinc-N-oxide): more about iron. Free Radical Res. Commun. 19:879-887.
6. Byrd, T. F., and M. A. Horwitz. 1989. Interferon gamma-activated human monocyles downregulate receptors and inhibit the intracellular multiplication of Lcgionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83:1457-1465.
7. Byrne, G. I., L. K. Lehmann, and G. J. Landry. 1986. Induction of L-tryplophan catabolism is the mechanism for gamma-interferon mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:347-351.
8. Degre, M., G. Sonnenfeld, H. Rollag, and B. Morland. 1981 Effect of gamma Interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages. J. Interferon Res. 1:505-512.
9. Diamond, R. D., C. A. Lyman, and D. R. Wysong. 1991. Disparate effects of interferon-gamma and tumor necrosis factor-alpha on Candida albicans hyphae in vitro. J. Clin. Invest. 87:711-720.
10. Dupont, G. P., T. P. Huecksteadt, B. C. Marshall, U. S. Ryan, J. R. Michael, and J. R. Hoidal. 1992. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J. Clin. Invest. 89:197-202.
11. Edwards, J. E., Jr., D. Rotrosen, J. W. Fontaine, C. C. Houdenschild, and R. D. Diamond. 1987. Neutrophil-mediated protection of cultured human vascular endothelial cells from damage by growing Candida albicans hyphae. Blood 69:1450-1457.
12. Filler, S. G., B. O. Ibe, P. M. Luckett, J. U. Raj, and J. E. Edwards, Jr. 1991. Candida albicans stimulates endothelial cell eicosanoid production. J. Infect. Dis. 164:928-935.
13. Filler, S. G., J. N. Swerdloff, C. Hobbs, and P. M. Luckett. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63:976-983.
14. Fratti, R. A. 1996. Endothelial cell injury caused by Candida alhicans is dependent on iron. M.S. thesis. California State University, Long Beach.
15. Gebran, S. J., Y. Yamamaoto, C. Newton, T. W. Klein, and H. Friedman. 1994. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect. Immun. 62:3197-3205.
16. Glancey, G., J. S. Cameron, C. Ogg, and S. Poston. 1993. Adherence of Staphylococcus aureus to cultures of human peritoneal mesothelial cells. Nephrol. Dial. Transplant. 8:157-162.
17. Gorog, P., J. D. Pearson, and V. V. Kakkar. 1988. Generation of reactive oxygen metabolites by phagocytosing endothelial cells. Atherosclerosis 72:19-27.
18. Gregory, S. H., and E. J. Wing. 1993. IFN-γ- inhibits the replication of Listeria monocytogenes in hepatocytcs. J. Immunol. 151:1401-1409.
19. Hiraishi, H., A. Terano, M. Razandi, A. Pedram, T. Sugimoto, T. Harada, and K. J. Ivey. 1994. Reactive oxygen metabolite-induced toxicity to cultured bovine endothelial cells: status of cellular iron mediating injury. J. Cell. Physiol. 160:132-140.
20. Ibrahim, A. S., S. G. Filler, M. A. Ghannoum, and J. E. Edwards, Jr. 1993. Interferon-gamma protects endothelial cells from damage by Candida albicans. J. Infect. Dis. 167:1467-1470.
21. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Ninick. 1973. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Invest. 52:2745-2756.
22. Kullerg, B. J., and J. W. van't Wout. 1994. Cytokines in the treatment of fungal infections. Biotherapy 7:195-210.
23. Kvietys, P. R., W. Inauen, B. R. Bacon, and M. B. Grisham. 1989. Xanthine oxidase-injury to endothelium: role of intracellular iron and hydroxyl radical. Am. J. Physiol. 257:H1640-H1646.
24. Lane, T. E., B. A. Wu-Hsieh, and D. H. Howard. 1991. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect. Immun. 59:2274-2278.
25. Levitz, S. M., D. J. DiBenedetto, and R. D. Diamond. 1987. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J. Immunol. Methods 101:37-42.
26. MacNaul, K. L., and N. I. Hutchinson. 1993. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem. Biophys. Res. Commun. 196:1330-1334.
27. Marodi, L., and R. B. Johnston, Jr. 1993. Enhancement of macrophage candidacidal activity by interferon-gamma. Immunodeficiency 4:181-185.
28. Odds, F. C. 1988. Candida and candidosis: a review and bibliography, p. 39-52. Bailliere Tindal, London.
29. Oswald, I. P., I. Elloum, T. A. Wynn, B. Schwartz, P. Caspar, D. Paulin, A. Sher, and S. L. James. 1994. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc. Natl. Acad. Sci. USA 91:999-1003.
30. Pakala, R., R. Pakala, and C. R. Benedict. 1995. Novel 21-aminosteroidlike compounds prevent iron-induced free radical-mediated injury to vascular endothelial cells. J. Cardiovasc. Pharmacol. 25:871-879.
31. Pfefferkorn, E. R. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade L-lryptophan. Proc. Natl. Acad. Sci. USA 81:908-912.
32. Pober, J., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427-451.
33. Rementeria, A., R. Garcia-Tobalina, and M. J. Sevilla. 1995. Nitric oxide-dependent killing of Candida albicans by murine peritoneal cells during an experimental infection. FEMS Immunol. Med. Microbiol. 11:157-162.
34. Renkonen, R. 1989. Regulation of intercellular adhesion molecule-1 expression on endothelial cells with correlation to lymphocyte-endothelial binding. Scand. J. Immunol. 29:717-721.
35. Roilides, E., and P. A. Pizzo. 1992. Modulation of host defenses by Cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin. Infect. Dis. 15:508-524.
36. Rollag, H., M. Degre, and G. Sonnenfeld. 1984. Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages. Scand. J. Immunol. 20:149-155.
37. Rotrosen, D., J. E. Edwards, Jr., T. R. Gibson, J. D. Moore, A. H. Cohen, and I. Green. 1985. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J. Infect. Dis. 152:1264-1273.
38. Schlesinger, L. S., and M. A. Horwitz. 1991. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147:1983-1994.
39. Schoedon, G., M. Schneemann, R. Walter, N. Blau, S. Hofer, and A. Schaffner. 1995. Nitric oxide and infection: another view. Clin. Infect. Dis. 21(Suppl. 2):S152-S157.
40. Stolpen, A. H., E. C. Guinan, W. Fiers, and J. S. Pober. 1986. Recombinant tumor necrosis factor and immune Interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am. J. Pathol. 123:16-24.
41. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1995. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63:1142-1144.
42. Werner-Felmayer, G., E. R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, K. Schmidt, G. Weiss, and H. Wachter. 1993. Pteridine biosynthesis in human endothelial cells. J. Biol. Chem. 268:1842-1846.
43. Woodman, J. P., I. H. Dimier, and D. T. Bout. 1991. Human endothelial cells are activated by IFN-γ to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J. Immunol. 147:2019-2023.